Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure

NCT01300650 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Anakinra

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]
[object Object]